Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2021-05-21 Capital/Financing Update
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the approval of a significant incoming investment of Rs. 433 crore by Morepen Laboratories Limited at an Extraordinary General Meeting (EGM). It details the issuance of equity shares and warrants to Corinth Investment Holdings and promoters, the purpose of the funds, and background information about the company and the investor. The document is not a full financial report, audit, or earnings release, but rather an announcement of a capital raising event approved at an EGM. It does not contain detailed financial statements or management discussion but focuses on the financing update and shareholder approval. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing event, not just a brief notice or report publication announcement.
2021-05-21 English
Please find enclosed press release - Morepen EGM approves Rs.433 Cr. incoming investment from Corinth and Promoters
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the approval of a significant incoming investment of Rs. 433 crore by Morepen Laboratories Limited at an Extraordinary General Meeting (EGM). It details the issuance of equity shares and warrants to Corinth Investment Holdings and promoters, the purpose of the funds, and background information about the company and the investor. There are no financial statements or detailed financial performance data presented, nor is this a transcript, audit report, or regulatory filing. The document is an announcement of a capital raising event approved at an EGM, which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the financing but does not constitute a full financial report or annual/interim report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-05-21 English
Shareholders meeting
Regulatory Filings
2021-05-21 English
Please find enclosed Voting Results of the Extra-Ordinary General Meeting ('EGM') of the members of Morepen Laboratories Limited held on Thursday, May 20, 2021 through video conferencing/ ....
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed report of the voting results from an Extra Ordinary General Meeting (EGM) held by Morepen Laboratories Limited on May 20, 2021. It includes information about the voting process, the resolutions passed, the scrutinizer's report, and the consolidated voting results. The document references the Companies Act, SEBI regulations, and the process of remote e-voting and e-voting during the meeting. It is not an announcement of a report publication but the actual voting results and scrutinizer's report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content confirm it is not a brief announcement or a proxy solicitation but a full voting results report.
2021-05-21 English
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Extra-Ordinary General Meeting of the ....
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the 'Proceedings of Extra-Ordinary General Meeting' held on May 20, 2021. It details the conduct of the meeting, including the chairman's address, the business discussed (issue of equity shares and fully convertible warrants on a preferential basis), and the voting process. It explicitly states that it is not the minutes of the meeting but a gist of the proceedings. There is no detailed financial data, no full report, or audit information. The document is a summary of what transpired during the EGM, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder meeting proceedings and voting outcomes. The document length is 4311 characters, which is relatively short but contains substantive content about the meeting proceedings and voting, not just an announcement of a report. Therefore, the best fit is DVA.
2021-05-20 English
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Extra-Ordinary General Meeting of the ....
Declaration of Voting Results & Voting Rights Announcements Classification · 75% confidence The document is titled as the 'Proceedings of Extra-Ordinary General Meeting' held on May 20, 2021. It details the conduct of the meeting, including the chairman's address, the business discussed (issue of equity shares and warrants on a preferential basis), and the voting process. It explicitly states that it is not the minutes of the meeting but a gist of the proceedings. There is no detailed financial data, no full report, and no voting results declared here. The document is a summary of the meeting proceedings rather than the voting results or a full report. Given the content and context, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the meeting and voting process, although it does not contain final voting results, it is the closest fit since it is about the meeting proceedings and voting process. However, since it explicitly states it is not the minutes and does not provide voting results, and it is a formal announcement related to the meeting, the best classification is DVA with moderate confidence.
2021-05-20 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.